Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Herpes zoster in an adult recipient of live attenuated varicella vaccine.

Hammerschlag MR, Gershon AA, Steinberg SP, Clarke L, Gelb LD.

J Infect Dis. 1989 Sep;160(3):535-7. Erratum in: J Infect Dis 1989 Dec;160(6):1095.

PMID:
2547882
2.

Immunization of healthy adults with live attenuated varicella vaccine.

Gershon AA, Steinberg SP, LaRussa P, Ferrara A, Hammerschlag M, Gelb L.

J Infect Dis. 1988 Jul;158(1):132-7. Erratum in: J Infect Dis 1988 Nov;158(5):1149.

PMID:
2839577
3.

Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.

Gelb LD, Dohner DE, Gershon AA, Steinberg SP, Waner JL, Takahashi M, Dennehy PH, Brown AE.

J Infect Dis. 1987 Apr;155(4):633-40.

PMID:
3029239
4.

Live attenuated varicella vaccine use in immunocompromised children and adults.

Gershon AA, Steinberg SP, Gelb L.

Pediatrics. 1986 Oct;78(4 Pt 2):757-62.

PMID:
3020495
5.

Varicella vaccine: the American experience.

Gershon AA, LaRussa P, Hardy I, Steinberg S, Silverstein S.

J Infect Dis. 1992 Aug;166 Suppl 1:S63-8. Review.

PMID:
1320652
8.

Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.

Uebe B, Sauerbrei A, Burdach S, Horneff G.

Eur J Pediatr. 2002 Aug;161(8):442-4. Epub 2002 Jun 25.

PMID:
12172829
9.

The risk of zoster after varicella vaccination in children with leukemia.

Lawrence R, Gershon AA, Holzman R, Steinberg SP.

N Engl J Med. 1988 Mar 3;318(9):543-8.

PMID:
2828948
10.

Differentiation of oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees and household contact.

Shiraki K, Horiuchi K, Asano Y, Yamanishi K, Takahashi M.

J Med Virol. 1991 Feb;33(2):128-32.

PMID:
1675658
11.

A multicentre trial of live attenuated varicella vaccine in children with leukaemia in remission.

Gershon AA, Steinberg S, Gelb L, Galasso G, Borkowsky W, LaRussa P, Ferrara A.

Postgrad Med J. 1985;61 Suppl 4:73-8.

PMID:
3014482
12.

Varicella-zoster virus. Prospects for active immunization.

Gershon AA.

Am J Clin Pathol. 1978 Jul;70(1 Suppl):170-4.

PMID:
210654
13.

Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells.

Levy O, Orange JS, Hibberd P, Steinberg S, LaRussa P, Weinberg A, Wilson SB, Shaulov A, Fleisher G, Geha RS, Bonilla FA, Exley M.

J Infect Dis. 2003 Oct 1;188(7):948-53. Epub 2003 Sep 26.

PMID:
14513412
15.

Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.

Quinlivan ML, Gershon AA, Steinberg SP, Breuer J.

J Infect Dis. 2004 Aug 15;190(4):793-6. Epub 2004 Jul 15.

PMID:
15272408
16.

Primary varicella after transplantation.

Scanlon-Kohlroser CA, Fan PY, Primack W, Stoff JS.

Am J Kidney Dis. 2002 Jun;39(6):1310-2.

PMID:
12046047
17.
18.

Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.

Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S, Arvin AM.

Pediatrics. 1991 Feb;87(2):166-70.

PMID:
1846236
19.

Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction.

Hughes P, LaRussa P, Pearce JM, Lepow M, Steinberg S, Gershon A.

J Pediatr. 1994 Jun;124(6):932-5.

PMID:
8201480
20.

Clinical reinfection with varicella-zoster virus.

Gershon AA, Steinberg SP, Gelb L.

J Infect Dis. 1984 Feb;149(2):137-42.

PMID:
6321605

Supplemental Content

Support Center